8 Best Debt Free Stocks to Buy Right Now
The market environment has become more complicated following the recent energy shock tied to the Iran conflict, with inflation concerns resurfacing just as expectations for rate cuts were starting to ...
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sculptor Capital Daniel S. Och | 3,000,000 | $261,930,000 | -15% | 2.7% |
| 2. | Madison Avenue Partners Eli Samaha | 2,624,751 | $229,167,010 | +4% | 9.85% |
| 3. | Citadel Investment Group Ken Griffin | 2,539,396 | $221,714,665 | +2166% | 0.03% |
| 4. | Vestal Point Capital Ryan Wilder | 1,275,000 | $111,320,250 | +2% | 3.78% |
| 5. | Parsifal Capital Management David Zorub | 1,222,717 | $106,755,421 | +11% | 8.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | $33,136.20 | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | $32,947.50 | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | $33,740.00 | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $94.50 | 20,000 | $1,890,000.00 | 0 | 2026-02-25 | Filing | |
| $87.67 | 10,000 | $876,700.00 | 0 | 2026-02-12 | Filing | |
| $101.10 | 3,594 | $363,353.40 | 0 | 2026-01-08 | Filing | |
| $101.10 | 2,000 | $202,200.00 | 10,419 | 2026-01-08 | Filing | |
| $88.85 | 4,000 | $355,400.00 | 12,419 | 2025-12-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,906 | $2,490,541 | 0.37% | |
| 2. | 34,749 | $2,006,334 | 0% | |
| 3. | 20,756 | $1,788,337 | 0.14% | |
| 4. | 11,929 | $1,048,798 | 0.03% | |
| 5. | 4,241 | $365,405 | 0.34% |
News See All
Globus Medical (GMED) Slips on Acquisition and Robotics Segment Challenges
Invesco Ltd‘s “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
Globus Medical, Inc. (NYSE:GMED) Q4 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Fourth Quarter and Full Year 2025 Earnings Call.
Globus Medical Inc. (GMED) Gains Positive Attention Amid Improving Outlook
Globus Medical Inc. (NYSE:GMED) is one of the best medical technology stocks to invest in. On January 30, Needham upgraded its rating on Globus Medical Inc.
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
Here's What Lifted Globus Medical (GMED) in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. U.S.
Varied Growth Drivers Led Antipodes Global Value Strategy to Add Globus Medical (GMED) to Its Portfolio
Antipodes Partners recently published its “Antipodes Global Value Strategy” third-quarter 2025 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook.
Globus Medical, Inc. (NYSE:GMED) Q3 2025 Earnings Call Transcript
Operator: Welcome to Globus Medical's Third Quarter 2025 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
Globus Medical (GMED) Sees Sequential Revenue Surge, Citizens JMP Maintains Market Perform Rating
Globus Medical Inc. (NYSE:GMED) ranks among the best mid-cap stocks with huge upside potential. Following the publication of Globus Medical Inc.
Hedge Fund Resource Center